[1]
|
Rasey JS, Grierson JR, Wiens LW, et al. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549carcinoma cells[J]. J Nucl Med, 2002, 43(9):1210-1217. |
[2]
|
Wagner M, Seitz U, Neumaier B, et al. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3' deoxythymidine ([18F]FLT) in pancreatic cancer cell lines[J]. Eur J Nucl Med Mol Imaging, 2002, 29(9):1174-1181. |
[3]
|
Barthel H, Cleij MC, Collingridge DR, et al. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography[J]. Cancer Res, 2003, 63(13):3791-3798. |
[4]
|
Dittmann H, Dohmen BM, Kehlbach R, et al. Early changes in[18F]FLT uptake after chemotherapy:an experimental study[J]. EurJ Nucl Med Mol Imaging, 2002, 29(11):1462-1469. |
[5]
|
Dittmann H, Dohmen BM, Paulsen F, et al.[18F] FLT PET for diagnosis and staging of thoracic tumours[J]. Eur J Nucl Med Mol Imaging, 2003, 30(10):1407-1412. |
[6]
|
Buck AK, Halter G, Schirrmeister H, et al. Imaging proliferation in lung tumors with PET:18F-FLT versus 18F-FDG[J]. J Nucl Med, 2003, 44(9):1426-1431. |
[7]
|
Buck AK, Schirrmeister H, Hetzel M, et al. 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules[J].Cancer Res, 2002, 62(12):3331-3334. |
[8]
|
Vesselle H, Grierson J, Muzi M, et al. In vivo validation of 3'-deoxy-3'-[18F]fluorothymidine ([18F] FLT) as a proliferation imaging tracer in humans:correlation of[18F] FLT uptake by positron emission tumography with Ki-67 immunohistochemistry and fl |
[9]
|
Francis DL, Visvikis D, Costa DC, et al. Potential impact of[18F]3'-deoxy-3'-fluorothymidine versus[18F] fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer[J]. Eur J Nucl Med Mol Imaging, 2003, 30(7):988-994. |
[10]
|
Wagner M, Seitz U, Buck A, et al. 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease[J]. Cancer Res 2003, 63(10):2681-2687. |
[11]
|
Lu L, Samuelsson L, Bergstrom M, et al. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BrFU as prolifera-tion markers[J]. J Nucl Med, 2002, 43(12):1688-1698. |